Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
DL-3-Hydroxybutyric acid sodium salt
41
CHF
CHF 41.00
In stock
CDX-H0080-G0011 gCHF 41.00
CDX-H0080-G01010 gCHF 122.00
| Product Details | |
|---|---|
| Synonyms | Sodium 3-hydroxybutyrate; β-Hydroxybutyrate sodium salt |
| Product Type | Chemical |
| Properties | |
| Formula |
C4H7NaO3 |
| MW | 126.1 |
| CAS | 150-83-4 |
| Source/Host Chemicals | Synthetic. |
| Purity Chemicals | ≥98% (NMR) |
| Appearance | White powder. |
| Identity | Determined by NMR. |
| Declaration | Manufactured by Chemodex. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| InChi Key | NBPUSGBJDWCHKC-UHFFFAOYSA-M |
| Smiles | [Na+].CC(O)CC([O-])=O |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Keep cool and dry. Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Neuroprotective compound in experimental models of neurodegenerative diseases. Shown to be oxidized as an energetic substrate in the brain during starvation. May inhibit brain glucose oxidation, which may account for the suppression of hepatic glucose production observed after administration of ketone bodies in humans.
Product References
(1) P. Bjorntorp & T. Schersten; Amer. J. Physiol. 212, 683 (1967) | (2) E. Balasse & H.A. Ooms; Diabetol. 4, 133 (1968) | (3) N. Hotta, et al.; Can. J. Physiol. Pharmacol. 49, 87 (1971) | (4) R. Chiolero, et al.; Am. J. Clin. Nutr. 58, 608 (1993) | (5) B. Plecko, et al.; Ped. Res. 52, 301 (2002) | (6) S. Thaler, et al.; Graefes Arch. Clin. Exp. Ophthalmol. 248, 1729 (2010)
Related Products
